Ionis Pharmaceuticals, Inc. Income (Loss) from Continuing Operations, Per Basic Share
Ionis Pharmaceuticals, Inc. (IONS) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.85 per share for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2012-02-29
- Ionis Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2010-09-30 was -$0.13.
- Ionis Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2010-06-30 was -$0.25.
- Ionis Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2009-09-30 was -$0.12.
- Ionis Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2009-06-30 was -$0.03.
- Ionis Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for fiscal 2011 was -$0.85.
- Ionis Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for fiscal 2010 was -$0.62.
- Ionis Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for fiscal 2009 was -$0.31.
- Ionis Pharmaceuticals, Inc. income (loss) from continuing operations, per basic share for fiscal 2008 was -$0.10.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|
| 2011-12-31 | -$0.85 10-K · filed 2012-02-29 | |||
| 2010-12-31 | -$0.62 10-K · filed 2012-02-29 | |||
| 2010-09-30 | -$0.13 10-Q · filed 2010-11-05 | -$0.48 10-Q · filed 2010-11-05 | ||
| 2010-06-30 | -$0.25 10-Q · filed 2010-08-09 | -$0.35 10-Q · filed 2010-08-09 | ||
| 2009-12-31 | -$0.31 10-K · filed 2012-02-29 | |||
| 2009-09-30 | -$0.12 10-Q · filed 2010-11-05 | -$0.16 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | -$0.03 10-Q · filed 2010-08-09 | -$0.03 10-Q · filed 2010-08-09 | ||
| 2008-12-31 | -$0.10 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |